Literature DB >> 21292085

Redo pull-through in Hirschsprung's [corrected] disease for obstructive symptoms due to residual aganglionosis and transition zone bowel.

Taiwo A Lawal1, Kaveer Chatoorgoon, Margaret H Collins, Alex Coe, Alberto Peña, Marc A Levitt.   

Abstract

BACKGROUND: Reoperations in Hirschsprung disease may be required for residual aganglionosis or transition-zone bowel found at the distal pull-through. We aimed to review the management of patients who had this complication and offer suggestions on how to avoid it.
METHODS: Ninety-three patients with Hirschsprung disease were referred to our institution with recurrent problems after a pull-through done elsewhere. All required reoperations with a variety of indications, and of these, 25 had residual aganglionosis/transition-zone histology. This was the only indication for redo in 16 children.
RESULTS: Children (range, 2-17 years) presented 6 to 66 months after the initial pull-through. The predominant symptoms were enterocolitis (n = 9 [56%]), constipation (n = 7 [44%]), failure to thrive (n = 5 [31%]), and impaction (n = 4 [25%]). The rectal biopsy performed as part of their post pull-through work up showed hypertrophic nerves (n = 16), absent ganglion cells (n = 6), and normal ganglion cells (n = 10). The original frozen-section biopsy, determining the level of the pull-through, only sampled the seromuscular layer in 3 children, leading to misdiagnosis. Reoperations involved a transanal resection (n = 15) and a posterior sagittal approach (n = 1). In all cases, obstructive symptoms were resolved, and no patient has had recurrent enterocolitis.
CONCLUSION: Patients' post pull-through with recurrent obstructive symptoms may have residual aganglionosis or transition-zone bowel. Reoperation can result in the resolution of these symptoms. A full-thickness biopsy at the time of the initial pull-through to include the mucosa and submucosa may increase the possibility of identifying hypertrophic nerves.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21292085     DOI: 10.1016/j.jpedsurg.2010.11.014

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  16 in total

Review 1.  Hirschsprung-associated enterocolitis: pathogenesis, treatment and prevention.

Authors:  Farokh R Demehri; Ihab F Halaweish; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2013-09       Impact factor: 1.827

Review 2.  Redo pullthrough for Hirschsprung disease.

Authors:  Matthew W Ralls; Arnold G Coran; Daniel H Teitelbaum
Journal:  Pediatr Surg Int       Date:  2016-12-31       Impact factor: 1.827

Review 3.  Tissue engineering for neuromuscular disorders of the gastrointestinal tract.

Authors:  Kenneth L Koch; Khalil N Bitar; John E Fortunato
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

4.  Predictive value of nerve trunk size in the neonate.

Authors:  Roxana Rassouli-Kirchmeier; Maarten Janssen Lok; Benno Kusters; Iris Nagtegaal; Nils Köster; Herjan van der Steeg; Marc Wijnen; Ivo de Blaauw
Journal:  Pediatr Surg Int       Date:  2014-07-05       Impact factor: 1.827

5.  Redo surgery with longitudinal resection for dilated bowel in Hirschsprung disease: an illustrative case series.

Authors:  Daniëlle Roorda; Tessa J Surridge; Ruben G J Visschers; Joep P M Derikx; L W Ernest van Heurn
Journal:  Int J Colorectal Dis       Date:  2019-10-19       Impact factor: 2.571

Review 6.  Residual aganglionosis after pull-through operation for Hirschsprung's disease: a systematic review and meta-analysis.

Authors:  Florian Friedmacher; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-10       Impact factor: 1.827

7.  Re-operation for Hirschsprung's disease: experience in 24 patients from China.

Authors:  Qingfeng Sheng; Zhibao Lv; Xianmin Xiao
Journal:  Pediatr Surg Int       Date:  2012-02-23       Impact factor: 1.827

8.  Surgical approach and functional outcome of redo pull-through for postoperative complications in Hirschsprung's disease.

Authors:  Qi Li; Zhen Zhang; Ping Xiao; Ya Ma; Yuchun Yan; Qian Jiang; Yee Low; Long Li
Journal:  Pediatr Surg Int       Date:  2021-08-20       Impact factor: 1.827

9.  Laparoscopic vs. Transabdominal Treatment for Overflow Fecal Incontinence Due to Residual Aganglionosis or Transition Zone Pathology in Hirschsprung's Disease Reoperation.

Authors:  Feng Chen; Xiaoyu Wei; Xiaohua Chen; Lei Xiang; Jiexiong Feng
Journal:  Front Pediatr       Date:  2021-04-27       Impact factor: 3.418

10.  Duhamel versus transanal endorectal pull through (TERPT) for the surgical treatment of Hirschsprung's disease.

Authors:  E Arts; S M B I Botden; M Lacher; P Sloots; M P Stanton; I Sugarman; T Wester; I de Blaauw
Journal:  Tech Coloproctol       Date:  2016-09-14       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.